Author

J‐M. Herbert

Observed names: J-M Herbert, J-M. Herbert, J.-M. Herbert

Institutions: Sanofi (France), Sanofi (Turkey)

Observed institutions: Inserm, Sanofi (France), Hôpital Purpan, Sanofi (Turkey)

OpenAlex ID: A5111814546

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

1999 · S. Heymans, A. Luttun, et al. · Nature Medicine · 803

Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species

1995 · C. Ravanat, M. Freund, et al. · Blood Coagulation & Fibrinolysis · 84

Hirudin ameliorates intestinal radiation toxicity in the rat: support for thrombin inhibition as strategy to minimize side‐effects after radiation therapy and as countermeasure against radiation exposure

2004 · J. Wang, H. Zheng, et al. · Journal of Thrombosis and Haemostasis · 65

Antithrombotic Properties of SSR182289A, a New, Orally Active Thrombin Inhibitor

2003 · J. Lorrain, L. Millet, et al. · Journal of Pharmacology and Experimental Therapeutics · 23

Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot-bound thrombin and factor Xa in vitro and in vivo

2003 · J-P. Hérault, M. Cappelle, et al. · Journal of Thrombosis and Haemostasis · 14

Comparative effects of two synthetic oligosaccharides on platelet activation induced by plasma from HIT patients

2003 · P. Savi, A-M. Pflieger, et al. · Journal of Thrombosis and Haemostasis · 6

SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis

2004 · C. Visconte, M. Sainte-Marie, et al. · Journal of Thrombosis and Haemostasis · 3

Paradoxical increase of plaque growth and collagen deposition in atherosclerotic mice lacking plasminogen activator inhibitor-1 (PAI-1)

2000 · A Luttun, J-M Herbert, et al. · Atherosclerosis

Works count: 8

Citation count: 998

H-index: 6

I10-index: 5